Professor Christopher Jackson

2026

Journal - Research Article

Tregear, M. L., Verduzco-Aguirre, H. C., Shkabari, B., Koven, R., Scowcroft, H., Venkatash, V., … Jackson, C. G. C. A. (2026). A common sense oncology values-to-action framework for patient-centered randomized trials in oncology. Clinical Cancer Research. Advance online publication. doi: 10.1093/jnci/djag092

Tregear, M. L., Verduzco-Aquirre, H. C., Shkabari, B., Koven, R., Scowcroft, H., Venkatash, V., … Jackson, C. G. C. A. (2026). Common sense oncology values to action: A patient led framework for randomized clinical trial design. Journal of the National Cancer Institute. Advance online publication. doi: 10.1093/jnci/djag092

Journal - Research Other

Wilson, B. E., Jackson, C., Tregear, M., & Booth, C. M. (2026). “While you are on chemotherapy ...”: Common recommendations that lack evidence and may cause harm. Journal of the National Cancer Institute, 118(3), 382-385. doi: 10.1093/jnci/djaf239

2025

Chapter in Book - Research

Jackson, C. G. C. A., & Gurney, J. (2025). Achieving seismic change in policy and practice: A New Zealand case study. In M. Giuliani, M. K. Gospodarowicz, J. D. Brierley & R. Sullivan (Eds.), Cancer systems and control for health professionals. (pp. 270-278). Hoboken, NJ: Wiley.

Journal - Research Article

Gurney, J., Ongley, D., Cameron, L., Costello, S., Davies, A., Dawkins, P., Jackson, C. G. C. A., … Stanley, J. (2025). Patterns of treatment prior to death among those with lung cancer: A national study in a universal healthcare context. Lung Cancer, 208, 108761. doi: 10.1016/j.lungcan.2025.108761

Davies, A., Stanley, J., Costello, S., Dunn, A., Dawkins, P., Jackson, C., … Gurney, J. (2025). Radiation therapy for lung cancer in Aotearoa New Zealand. Cancer Causes & Control, 36, 1719-1730. doi: 10.1007/s10552-025-02052-w

Helsby, N., Sharples, K., Kim, Y. J., Porter, D., Burns, K., Jeong, S. H., … Jackson, C., … Findlay, M. (2025). A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity. Cancer Chemotherapy & Pharmacology, 95, 81. doi: 10.1007/s00280-025-04804-6

Gurney, J., Ballantine, K., Chiang, A., Davies, A., Jackson, C. G. C. A., Koea, J., Stanley, J., & Macfarlane, S. (2025). Child and adolescent/young adult cancer incidence and survival for Māori in Aotearoa New Zealand. Cancer Epidemiology, 97, 102868. doi: 10.1016/j.canep.2025.102868

Gurney, J., Davies, A., Stanley, J., Dunn, A., Cameron, L., Costello, S., … Jackson, C. G. C. A. (2025). National variation in the treatment of lung cancer in a universal healthcare context. British Journal of Cancer, 133, 346-352. doi: 10.1038/s41416-025-03071-9

Hossain, S. M., Gimenez, G., Stockwell, P., Weeks, R., Almomani, S., Jones, G. T., Ratajska, M., Shuen, M., Bhat, B., … Rodger, E., Jackson, C., Chatterjee, A., & Eccles, M. R. (2025). Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy. Cancer Letters, 618, 217638. doi: 10.1016/j.canlet.2025.217638

Teng, A., Stanley, J., Krebs, J., Jackson, C. G. C. A., Koea, J., Scott, N., Sika-Paotonu, D., Stairmand, J., … Gurney, J. (2025). Projected increases in the prevalence of diabetes mellitus in Aotearoa New Zealand, 2020–2044. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1608), 94-106. Retrieved from https://www.nzmj.org.nz/

Journal - Research Other

Stevens, S. X., Jackson, C. G. C. A., & Karikios, D. (2025). What is the role of common sense oncology in the Western Pacific? Lancet Regional Health: Western Pacific, 61, 101660. doi: 10.1016/j.lanwpc.2025.101660

Gurney, J., Stanley, J., Davies, A., Signal, V., Dawkins, P., Cameron, L., Costello, S., Jackson, C. G. C. A., … Whitehead, J., & Koea, J. (2025). Improving lung cancer survival outcomes for Māori. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1618), 96-103. doi: 10.26635/6965.6947

Gurney, J., & Jackson, C. (2025). Cancer prevention: The wero we are called to meet. Journal of the Royal Society of New Zealand, 55(5), 1187-1189. doi: 10.1080/03036758.2025.2529018

2024

Journal - Research Article

Wang, D., Hung, N., Hung, T., Eden, K., Chan, W.-K., Kwan, R., … Duffull, S., Glue, P., & Jackson, C. (2024). Oral docetaxel plus encequidar: A phase 1 clinical trial. Cancer Chemotherapy & Pharmacology, 94, 475-481. doi: 10.1007/s00280-024-04674-4

Wang, D., Hughes-Medlicott, N., Klingler, L., Wang, Y., Hung, N., Duffull, S., … Glue, P., … Jackson, C. (2024). A sensitive assay for unbound docetaxel using ultrafiltration plus HPLC-MS and its application to a clinical study. Pharmaceutics, 16, 602. doi: 10.3390/pharmaceutics16050602

Wang, D., Jackson, C., Hung, N., Hung, T., Kwan, R., Chan, W.-K., … Hughes-Medlicott, N. J., Glue, P., & Duffull, S. (2024). Oral docetaxel plus encequidar: A pharmacokinetic model and evaluation against IV docetaxel. Journal of Pharmacokinetics & Pharmacodynamics, 51, 335-352. doi: 10.1007/s10928-024-09913-y

Gurney, J., Davies, A., Stanley, J., Whitehead, J., Costello, S., Dawkins, P., … Jackson, C. G. C. A., Lawrenson, R., Scott, N., & Koea, J. (2024). Equity of travel to access surgery and radiation therapy for lung cancer in New Zealand. Supportive Care in Cancer, 32, 171. doi: 10.1007/s00520-024-08375-9

Gurney, J., Davies, A., Stanley, J., Cameron, L., Costello, S., Dawkins, P., … Jackson, C. G. C. A., Lawrenson, R., Whitehead, J., & Koea, J. (2024). Access to and timeliness of lung cancer surgery, radiation therapy, and systemic therapy in New Zealand: A universal health care context. JCO Global Oncology, 10, e2300258. doi: 10.1200/GO.23.00258

Teng, A., Stanley, J., Jackson, C., Koea, J., Lao, C., Lawrenson, R., … Sika-Paotonu, D., & Gurney, J. (2024). The growing cancer burden: Age-period-cohort projections in Aotearoa New Zealand 2020-2044. Cancer Epidemiology, 89, 102535. doi: 10.1016/j.canep.2024.102535

Minhinnick, A. M., Dunn, A. H., Arabnejad, V., Paddison, J., Jackson, C. G. C. A., Pointer, S. M., Gurney, J. K., & Cameron, L. B. (2024). Use of novel national data sets to monitor chemotherapy use and outcomes: A retrospective cohort study of non-small-cell lung cancer in Aotearoa New Zealand. JCO Oncology Practice, 20(3), 401-408. doi: 10.1200/op.23.00483

Anaka, M., Chan, D., Pattison, S., Thawer, A., Franco, B., Moody, L., Jackson, C., … Singh, S. (2024). Patient priorities concerning treatment decisions for advanced neuroendocrine tumors identified by discrete choice experiments. Oncologist, 29, 227-234. doi: 10.1093/oncolo/oyad312

Journal - Research Other

Towns, C., Brockway, B., Jackson, C., & Burgess, S. (2024). Duty of care? Tobacco laws and doctors in parliament. Tobacco Control, 33(6), 699-700. doi: 10.1136/tc-2024-058983

Robb, T. J., Liu, Y., Woodhouse, B., Windahl, C., Hurley, D., McArthur, G., … Guilford, P., … Jackson, C., … Lawrence, B. (2024). Blending space and time to talk about cancer in extended reality. npj Digital Medicine, 7, 261. doi: 10.1038/s41746-024-01262-x

Signal, V., Smith, M., Costello, S., Davies, A., Dawkins, P., Jackson, C. G. C. A., Koea, J., Whitehead, J., & Gurney, J. (2024). Indigenous access to clinical services along the lung cancer treatment pathway: A review of current evidence. Cancer Causes & Control, 35, 1497-1507. doi: 10.1007/s10552-024-01904-1

Wang, D., Hung, T., Hung, N., Glue, P., Jackson, C., & Duffull, S. (2024). Optimal sample selection applied to information rich, dense data. Journal of Pharmacokinetics & Pharmacodynamics, 1, 33-37. doi: 10.1007/s10928-023-09883-7

2023

Journal - Research Article

Dai, M.-S., Chao, T.-C., Chiu, C.-F., Lu, Y.-S., Shiah, H.-S., Jackson, C. G. C. A., Hung, N., … Chao, T.-Y. (2023). Oral paclitaxel and encequidar in patients with breast cancer: A pharmacokinetic, safety, and antitumor activity study. Therapeutic Advances in Medical Oncology, 15. doi: 10.1177/17588359231183680

Jenei, K., Raymakers, A. J. N., Bayle, A., Berger-Thürmel, K., Cherla, A., Honda, K., Jackson, C. G. C. A., … Gyawali, B. (2023). Health technology assessment for cancer medicines across the G7 countries and Oceania: An international, cross-sectional study. Lancet Oncology, 24, 624-635. doi: 10.1016/S1470-2045(23)00175-4

Fitzgerald, S., Blenkiron, C., Stephens, R., Mathy, J. A., Somers-Edgar, T., Rolfe, G., … Jackson, C., Eccles, M., … Rodger, E., … Guilford, P., … Print, C. G. (2023). Dynamic ctDNA mutational complexity in patients with melanoma receiving immunotherapy. Molecular Diagnosis & Therapy, 27, 537-550. doi: 10.1007/s40291-023-00651-4

Gurney, J., Davies, A., Stanley, J., Signal, V., Costello, S., Dawkins, P., … Jackson, C., … Koea, J. (2023). Emergency presentation prior to lung cancer diagnosis: A national-level examination of disparities and survival outcomes. Lung Cancer, 179, 107174. doi: 10.1016/j.lungcan.2023.03.010

Journal - Research Other

Booth, C. M., Sengar, M., Goodman, A., Wilson, B., Aggarwal, A., Berry, S., … Jackson, C., … Gyawali, B. (2023). Common Sense Oncology: Outcomes that matter. Lancet Oncology, 24(8), 833-835. doi: 10.1016/S1470-2045(23)00319-4

Conference Contribution - Published proceedings: Abstract

Blackmore, T., Norman, K., Kidd, J., Cassim, S., Chepulis, L., Keenan, R., … Jackson, C., Stokes, T., … Lawrenson, R. (2023). Barriers and facilitators to colorectal cancer diagnosis in New Zealand: A qualitative study. Australian Journal of Primary Health, 29(4), (pp. xii). doi: 10.1071/PYv29n4abs

Other Research Output

Jackson, C. (2023, May). At the crossroads of cancer care. University of Otago, Dunedin, New Zealand. [Inaugural Professorial Lecture].

2022

Journal - Research Article

Hossain, S. M., Gimenez, G., Stockwell, P. A., Tsai, P., Print, C. G., Rys, J., … Jackson, C., Chatterjee, A., & Eccles, M. R. (2022). Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures. Frontiers in Immunology, 13, 955063. doi: 10.3389/fimmu.2022.955063

Gurney, J. K., Dunn, A., Liu, M., Mako, M., Millar, E., Ruka, M., Crengle, S., … Jackson, C., … Sarfati, D. (2022). The impact of COVID-19 on lung cancer detection, diagnosis and treatment for Māori in Aotearoa New Zealand. New Zealand Medical Journal, 135(1556), 23-43. Retrieved from https://www.nzma.org.nz/journal

He, J., Jackson, C. G. C. A., Deva, S., Hung, T., Clarke, K., Segelov, E., … Zhi, J. (2022). Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors. CPT: Pharmacometrics & Systems Pharmacology, 11, 867-879. doi: 10.1002/psp4.12799

McPhail, S., Swann, R., Johnson, S. A., Barclay, M. E., Abd Elkader, H., Alvi, R., … Jackson, C. G. C. A., … ICBP Module 9 Emergency Presentations Working Group. (2022). Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): An International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncology, 23, 587-600. doi: 10.1016/s1470-2045(22)00127-9

Journal - Research Other

Pavlakis, N., Tincknell, G., Lim, L. E., Muro, K., Obermannova, R., Lorenzen, S., … Jackson, C., … Lordick, F. (2022). European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: Current practice and new directions. Therapeutic Advances in Medical Oncology, 14. doi: 10.1177/17588359221118874

Mason, K., Kelly, L., Jackson, C., Read, D., & Borman, B. (2022). Did new treatments contribute to a decrease in melanoma deaths? New Zealand Medical Journal, 135(1558), 90-95. Retrieved from https://journal.nzma.org.nz

Conference Contribution - Verbal presentation and other Conference outputs

Fitzgerald, S., Blenkiron, C., Somers-Edgar, T., Rolfe, G., Rykers, A., Stephens, R., … Jackson, C., Cocadiz, J. A., Zou, D., Eccles, M., Day, R., Guilford, P., … Print, C. (2022, August). Evolving genomic complexity unveiled in ctDNA analysis of melanoma patients. Verbal presentation at the Cancer Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.

Wang, D., Jackson, C., Glue, P., Hung, N., Hung, T., & Duffull, S. (2022, August-September). Exploring go/no-go with oral docetaxel plus encequidar. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.

2021

Journal - Research Article

Jackson, C. G. C. A., Hung, T., Segelov, E., Barlow, P., Prenen, H., McLaren, B., Hung, N. A., Clarke, K., … Deva, S. (2021). Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study. British Journal of Clinical Pharmacology, 87, 4673-4683. doi: 10.1111/bcp.14886

Millar, E., Gurney, J., Beuker, S., Goza, M., Hamilton, M.-A., Hardie, C., Jackson, C. G. C. A., … Sarfati, D. (2021). Maintaining cancer services during the COVID-19 pandemic: The Aotearoa New Zealand experience. Lancet Regional Health: Western Pacific, 11, 100172. doi: 10.1016/j.lanwpc.2021.100172

Gurney, J. K., Millar, E., Dunn, A., Pirie, R., Mako, M., Manderson, J., … Jackson, C. G. C. A., … Sarfati, D. (2021). The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand: A country pursuing COVID-19 elimination. Lancet Regional Health: Western Pacific, 10, 100127. doi: 10.1016/j.lanwpc.2021.100127

Morgan, E., Soerjomataram, I., Gavin, A. T., Rutherford, M. J., Gatenby, P., Bardot, A., … Jackson, C., … Arnold, M. (2021). International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut, 70, 234-242. doi: 10.1136/gutjnl-2020-321089

Conference Contribution - Verbal presentation and other Conference outputs

Gurney, J., Jackson, C., & Mako, M. (2021, September). Equity in cancer for Māori: Creating evidence, energy and action. Verbal presentation at the Achieving Health Equity from Research Conference [Otago Spotlight Series], Wellington, New Zealand.

2020

Journal - Research Article

Blackmore, T., Norman, K., Kidd, J., Cassim, S., Chepulis, L., Keenan, R., … Jackson, C., Stokes, T., … Lawrenson, R. (2020). Barriers and facilitators to colorectal cancer diagnosis in New Zealand: A qualitative study. BMC Family Practice, 21, 206. doi: 10.1186/s12875-020-01276-w

Zou, D., Day, R., Cocadiz, J. A., Parackal, S., Mitchell, W., Black, M. A., … Jackson, C., & Guilford, P. (2020). Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer. Carcinogenesis, 41(11), 1507-1517. doi: 10.1093/carcin/bgaa102

Gurney, J., Stanley, J., McLeod, M., Koea, J., Jackson, C., & Sarfati, D. (2020). Disparities in cancer-specific survival between Māori and non-Māori New Zealanders, 2007-2016. JCO Global Oncology, 6, 766-774. doi: 10.1200/go.20.00028

Segelov, E., Underhill, C., Prenen, H., Karapetis, C., Jackson, C., Nott, L., … MacIntyre, C. R. (2020). Practical considerations for treating patients with cancer in the COVID-19 pandemic. JCO Oncology Practice, 16(8), 467-482. doi: 10.1200/op.20.00229

Gurney, J., Stanley, J., Jackson, C., & Sarfati, D. (2020). Stage at diagnosis for Māori cancer patients: Disparities, similarities and data limitations. New Zealand Medical Journal, 133(1508), 43-64. Retrieved from https://www.nzma.org.nz/journal

Jackson, C. G. C. A., Bissett, I., Macfarlane, S., & Costello, S. (2020). Improving cancer services and survival in New Zealand. Journal of Cancer Policy, 23, 100216. doi: 10.1016/j.jcpo.2020.100216

Walker, S., Egan, R., Young, J., Jaye, C., & Jackson, C. (2020). A citizens' jury on euthanasia/assisted dying: Does informed deliberation change people's views? Health Expectations, 23, 388-395. doi: 10.1111/hex.13008

Journal - Research Other

Weinkove, R., McQuilten, Z. K., Adler, J., Agar, M. R., Blyth, E., Cheng, A. C., … Jackson, C., … Teh, B. W. (2020). Managing haematology and oncology patients during the COVID-19 pandemic: Interim consensus guidance. Medical Journal of Australia, 212(10), 481-489. doi: 10.5694/mja2.50607

Sarfati, D., & Jackson, C. G. C. A. (2020). Preface to the NZ series on Cancer Control. Journal of Cancer Policy, 23, 100223. doi: 10.1016/j.jcpo.2020.100223

Sarfati, D., & Jackson, C. (2020). Context of cancer control in New Zealand. Journal of Cancer Policy, 23, 100211. doi: 10.1016/j.jcpo.2019.100211

Conference Contribution - Published proceedings: Abstract

Jackson, C. G. C. A., & Sarfati, D. (2020). Achieving national cancer governance reform: Lessons from a successful academic, clinical, and community advocacy approach in New Zealand. Journal of Clinical Oncology, 38(15, Suppl.), e14131. doi: 10.1200/JCO.2020.38.15_suppl.e14131

2019

Journal - Research Article

So, Y. J., Jameson, M., Newton, V., O'Donnell, A., Jeffery, M., Jackson, C., … Wilson, M. K. (2019). Investigating strategies to improve clinical trial opportunities for patients with cancer in New Zealand: INSIGHT. New Zealand Medical Journal, 132(1498), 10-31. Retrieved from https://www.nzma.org.nz/journal

Young, J., Egan, R., Walker, S., Graham-DeMello, A., & Jackson, C. (2019). The euthanasia debate: Synthesising the evidence on New Zealander's attitudes. Kōtuitui, 14(1), 1-21. doi: 10.1080/1177083X.2018.1532915

Journal - Research Other

Gurney, J., Campbell, S., Jackson, C., & Sarfati, D. (2019). Equity by 2030: Achieving equity in survival for Māori cancer patients. New Zealand Medical Journal, 132(1506), 66-76. Retrieved from https://www.nzma.org.nz/journal

Jackson, C. G. C. A., Morris, T., Hung, N., & Hung, T. (2019). Breast milk paclitaxel excretion following intravenous chemotherapy: A case report. British Journal of Cancer, 121, 421-424. doi: 10.1038/s41416-019-0529-z

Sarfati, D., Jackson, C. G. C. A., Macfarlane, S., Bissett, I., Robson, B., Gurney, J., Kemp, R., … McMenamin, J. (2019). Cancer Care at a Crossroads: Time to make a choice. New Zealand Medical Journal, 132(1493), 6-11. Retrieved from https://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Jackson, C. G. C. A., Deva, S., Bayston, K., McLaren, B., Barlow, P., Hung, N. A., … Hung, C.-T. (2019). An international randomized cross-over bio-equivalence study of oral paclitaxel + HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours. Annals of Oncology, 30(Suppl. 5), mdz244.039. doi: 10.1093/annonc/mdz244.039

Conference Contribution - Verbal presentation and other Conference outputs

Jackson, C. (2019, January-February). The changing face and changing pace of cancer care in the clinic. Verbal presentation at the Cancer Care at a Crossroads Conference, Wellington, New Zealand.

2018

Journal - Research Article

Lawrence, B., Blenkiron, C., Parker, K., Tsai, P., Fitzgerald, S., Shields, P., … Black, M., … Robinson, B., … Carroll, R., … Morrin, H., … Jackson, C., … Print, C. (2018). Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer. npj Genomic Medicine, 3, 18. doi: 10.1038/s41525-018-0058-3

Gibbs, P., Heinemann, V., Sharma, N. K., Taieb, J., Ricke, J., Peeters, M., … Robinson, B., Jackson, C., … for the SIRFLOX and FOXFIRE Global Trial Investigators, including Perez, D. (2018). Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy: Combined analysis of two randomized controlled studies. Clinical Colorectal Cancer, 17(4), e617-e629. doi: 10.1016/j.clcc.2018.06.001

Sharples, K., Firth, M., Hinder, V., Hill, A., Jeffery, M., Sarfati, D., … Atmore, C., … Derrett, S., … Keating, J., … Jackson, C., & Findlay, M. (2018). The New Zealand PIPER Project: Colorectal cancer survival according to rurality, ethnicity and socioeconomic deprivation: Results from a retrospective cohort study. New Zealand Medical Journal, 1476(131), 24-39. Retrieved from https://www.nzma.org.nz/journal

Hill, A. G., Findlay, M. P., Burge, M. E., Jackson, C., Alfonso, P. G., Samuel, L., … Tabernero, J. (2018). Phase II study of the dual EGFR/HER3 inhibitor duligotuzumab (MEHD7945A) versus cetuximab in combination with FOLFIRI in second-line RAS wild-type metastatic colorectal cancer. Clinical Cancer Research, 24(10), 2276-2284. doi: 10.1158/1078-0432.Ccr-17-0646

Journal - Research Other

Sarfati, D., & Jackson, C. (2018). Cancer inequalities endure despite NHS reforms. BMJ, 360, k989. doi: 10.1136/bmj.k989

Conference Contribution - Published proceedings: Abstract

Fitzgerald, S., Lasham, A., Blenkiron, C., Shields, P., Rolfe, G., Stephens, R., … Jackson, C., Rodger, E., Eccles, M., Day, R., Guilford, P., … Print, C. (2018). Development of plasma genomic biomarkers for mutation detection and monitoring in New Zealand cancer patients. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/

Conference Contribution - Poster Presentation (not in published proceedings)

Fitzgerald, S., Lasham, A., Blenkiron, C., Shields, P., Rolfe, G., Stephens, R., … Jackson, C., Rodger, E., Eccles, M., Day, R., Guilford, P., … Print, C. (2018, August). Development of plasma genomic biomarkers for mutation detection and monitoring in New Zealand cancer patients. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Shields, N. J., Young, K. A., Jackson, C., & Young, S. L. (2018, August). Tumour cell-derived proteases contribute to antigen processing and enhance cross-presentation. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.

2017

Journal - Research Article

Li, K., Donaldson, B., Young, V., Ward, V., Jackson, C., Baird, M., & Young, S. (2017). Adoptive cell therapy with CD4⁺ T helper 1 cells and CD8⁺ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes. Clinical & Translational Immunology, 6(10), e160. doi: 10.1038/cti.2017.37

Segelov, E., Chan, D., Lawrence, B., Pavlakis, N., Kennecke, H. F., Jackson, C., … Singh, S. (2017). Identifying and prioritizing gaps in neuroendocrine tumor research: A modified Delphi process with patients and health care providers to set the research action plan for the newly formed Commonwealth Neuroendocrine Tumor Collaboration. Journal of Global Oncology, 3(4), 380-388. doi: 10.1200/jgo.2016.006916

Grant, M. L., Shields, N., Neumann, S., Kramer, K., Bonato, A., Jackson, C., Baird, M. A., & Young, S. L. (2017). Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8⁺ T cells. Clinical & Translational Immunology, 6(7), e149. doi: 10.1038/cti.2017.28

Tiong, J., Gray, A., Jackson, C., Thompson-Fawcett, M., & Schultz, M. (2017). Audit of the association between length of time spent on diagnostic work-up and tumour stage in patients with symptomatic colon cancer. ANZ Journal of Surgery, 87(3), 138-142. doi: 10.1111/ans.12804

Journal - Research Other

Lim, Y. K., Jackson, C., Dauway, E. L., & Richter, K. K. (2017). Risk factors for adverse outcome for elderly patients undergoing curative oncological resection for gastrointestinal malignancies. Visceral Medicine, 33(4), 254-261. doi: 10.1159/000475938

Conference Contribution - Published proceedings: Abstract

Jackson, C. G. C. A., Deva, S., Bayston, K., Barlow, P., Eden, K., Hung, N., … Hung, T. (2017). An open-label, randomized cross-over bioavailability study of oral paclitaxel and HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours. Annals of Oncology, 28(Suppl. 10), mdx568. doi: 10.1093/annonc/mdx658

Young, S., Li, K., Baird, M., Ward, V., Jackson, C., & Ronchese, F. (2017). Adoptive cell therapy with CD4⁺ T helper 1 cells and CD8⁺ cytotoxic T cells enhances complete rejection of an established tumour. Proceedings of the 46th Australasian Society for Immunology (ASI) Annual Scientific Meeting. 134. Retrieved from http://www.asi2017.org/

Shields, N., Grant, M., Young, K., Jackson, C., & Young, S. (2017). Comparison of tumor lysate preparations for the expansion of tumor-specific T cells. Proceedings of the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference. (pp. 86-87). Retrieved from http://www.cancerimmunotherapyconference.org

Segelov, E., Chan, D. L., Lawrence, B., Pavlakis, N., Kennecke, H., Jackson, C., … Singh, S. (2017). Identifying and prioritizing gaps in neuroendocrine tumor research-results of the Delphi Consensus Project of the Commonwealth Neuroendocrine Tumor Research Collaboration (CommNETS). Pancreas, 46(3), (pp. 450). doi: 10.1097/MPA.0000000000000812

Conference Contribution - Verbal presentation and other Conference outputs

Parker, K., Coats, E., Woodhouse, B., Knowlton, N., Schmiedel, O., Carroll, R., … Jackson, C., … Lawrence, B. (2017, October). The NETwork! registry: Preliminary data suggests increasing incidence in a national study of neuroendocrine cancer in New Zealand (NZ). Verbal presentation at the 19th Annual Scientific Meeting of the Australasian Gastro-Intestinal Trials Group (AGITG): Trials in Action, Cairns, Australia.

Atkinson, V., Jackson, C., Heppner, P., & Chiara Formenti, S. (2017, October). Management of brain metastases in the era of immune checkpoint blockade. Panel discussion at the New Zealand Society for Oncology (NZSO) Conference, Auckland, New Zealand.

Jackson, C. (2017, August). The changing landscape of cancer care in NZ. Verbal presentation at the 8th South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

Jackson, C. (2017, August). Priorities for cancer care in NZ: The Cancer Society's view. Plenary presentation at the 8th South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

2016

Journal - Research Article

Li, K., Baird, M., Yang, J., Jackson, C., Ronchese, F., & Young, S. (2016). Conditions for the generation of cytotoxic CD4⁺ Th cells that enhance CD8⁺ CTL-mediated tumor regression. Clinical & Translational Immunology, 5(8), e95. doi: 10.1038/cti.2016.46

Firth, M. J., Sharples, K. J., Hinder, V. A., Macapagal, J., Sarfati, D., Derrett, S. L., … Atmore, C., Keating, J. P., Jeffery, M., … Jackson, C. G. C. A., & Findlay, M. P. N. (2016). Methods of a national colorectal cancer cohort study: The PIPER Project. New Zealand Medical Journal, 129(1440), 25-36. Retrieved from https://www.nzma.org.nz/journal

Sarfati, D., Koczwara, B., & Jackson, C. (2016). The impact of comorbidity on cancer and its treatment. CA: A Cancer Journal for Clinicians, 66(4), 337-350. doi: 10.3322/caac.21342

Journal - Research Other

Jackson, C. G. C. A., & Sarfati, D. (2016). How 'modifiable' are 'modifiable risk factors' for cancer? New Zealand Medical Journal, 129(1447), 7-9. Retrieved from http://www.nzma.org.nz/journal

Jackson, C. G. C. A. (2016). Follow-up of cancer in New Zealand: Time to review the model of care. New Zealand Medical Journal, 129(1440), 18-21. Retrieved from https://www.nzma.org.nz/journal

Conference Contribution - Verbal presentation and other Conference outputs

Jackson, C. (2016, August-September). ORAXOL: New Zealand’s role in the development of a novel oral chemotherapy agent. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Jackson, C. (2016, August). Common primary care problems in patients on cancer treatments. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

Jackson, C. (2016, August). A paradigm shift in the treatment of advanced melanoma. Verbal presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

Other Research Output

Jackson, C., Robertson, S., Richards, R., Manning, P., Young, S. & Wilkins, G. (2016, November). The future face of healthcare. Dunedin School of Medicine Lecture Series, Dunedin Public Art Gallery, New Zealand. Retrieved from http://www.otago.ac.nz/dsm/about/otago625813.html

2015

Journal - Research Article

Stairmand, J., Signal, L., Sarfati, D., Jackson, C., Batten, L., Holdaway, M., & Cunningham, C. (2015). Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: A systematic review. Annals of Oncology, 26, 1325-1332. doi: 10.1093/annonc/mdv025

Conference Contribution - Published proceedings: Abstract

Jackson, C. G. C. A., Sharples, K. J., Murray, M. J., Hinder, V. A., Bramley, D. M., Brown, C., Derrett, S., … Keating, J. P., … Reid, P., Sarfati, D., Secker, A., & Findlay, M. P. N. (2015). Patient presentation, quality of care, and overall survival in colorectal cancer: Results from the New Zealand PIPER Cohort Study. Journal of Clinical Oncology, 33(15, Suppl.), e17637. Retrieved from http://jco.ascopubs.org/

Grant, M. L., Jackson, C., & Young, S. L. (2015). Two heads are better than one: Dendritic cells and B cells enhance the anti-tumour immune response compared with dendritic cells alone. New Zealand Medical Journal, 128(1425). Retrieved from http://www.nzma.org.nz/journal

Hill, A. G., Findlay, M., Burge, M., Jackson, C., Alfonso, P. G., Samuel, L., … Jeffery, M., … Tabernero, J. (2015). Randomized phase II study of duligotuzumab + FOLFIRI versus cetuximab + FOLFIRI in 2nd-line patients with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). Cancer Research, 75(15, Suppl.), CT-110. doi: 10.1158/1538-7445.AM2015-CT110

Conference Contribution - Poster Presentation (not in published proceedings)

Grant, M., Jackson, C., & Young, S. (2015, October). Two heads are better than one: Dendritic cells and B cells enhance the anti-tumour immune response compared with dendritic cells alone. Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.

Ibrahim, A., Jackson, C., Derrett, S., & Samaranayaka, A. (2015, October). Colonoscopy referral criteria in faster cancer treatment pathway for patients at Southern District Health Board. Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Jackson, C. (2015, August-September). The management of colorectal cancer in New Zealand: Outcomes from the PIPER project. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Jackson, C. (2015, November). Latest chemotherapeutic options for CRC. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Section Annual Scientific Meeting, Rotorua, New Zealand.

Jackson, C. (2015, October). Improving patient outcomes in colorectal cancer care. Verbal presentation at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.

2014

Journal - Research Article

Jackson, C. G. C. A., Sharples, K., Thompson, P. I., O'Donnell, A., Robinson, B. A., Perez, D. J., … Findlay, M. P. (2014). Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: A multi-centre phase II study. BMC Cancer, 14, 737. doi: 10.1186/1471-2407-14-737

Journal - Research Other

Jackson, C., Ehrenberg, N., Frizelle, F., Sarfati, D., Balasingham, A., Pearse, M., … Bissett, I. (2014). Rectal cancer: Future directions and priorities for treatment, research and policy in New Zealand. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal

Jackson, C., Robinson, B., & Findlay, M. (2014). Cancer services to 2025 in New Zealand: Investing in research-driven quality care. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Verbal presentation and other Conference outputs

Jackson, C. (2014, October). Colorectal cancer in New Zealand: The PIPER Project. Verbal presentation at the New Zealand Society for Oncology (NZSO) Conference, Tauranga, New Zealand.

Jackson, C. (2014, August). Survivorship in cancer. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Dunedin, New Zealand.

Jackson, C. (2014, August). The impact of malignancy. Verbal presentation at the South General Practice Conference & Medical Exhibition (GP CME), Dunedin, New Zealand.

Jackson, C. (2014, August). Initiatives and challenges. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Dunedin, New Zealand.

Jackson, C., Sarfati, D., & Bartlett, A. (2014, June). Colorectal cancer in NZ. Workshop presentation at the General Practice Conference & Medical Exhibition (GP CME), Rotorua, New Zealand.

Jackson, C. (2014, June). Colorectal cancer: NZ's cancer. Verbal presentation at the General Practice Conference & Medical Exhibition (GP CME), Rotorua, New Zealand.

2013

Journal - Research Article

Moorcraft, S. Y., Chau, I., Peckitt, C., Cunningham, D., Rao, S., Yim, K. L., … Jackson, C. G. C. A., … Swanton, C. (2013). Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: Results of the Phase II CINATRA trial. Investigational New Drugs, 31(5), 1339-1344. doi: 10.1007/s10637-013-9990-3

Bidwell, S., Simpson, A., Sullivan, R., Robinson, B., Thomas, W., Jackson, C., … Clarke, T. (2013). A workforce survey of New Zealand medical oncologists. New Zealand Medical Journal, 126(1371). Retrieved from http://www.nzma.org.nz/journal

Journal - Research Other

Jackson, C., McCall, J., Robinson, B., Sharples, K., & Findlay, M. (2013). Cancer trials in New Zealand: Patients are not the problem. New Zealand Medical Journal, 126(1381). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Grant, M., Jackson, C., & Young, S. (2013). Two heads are better than one: Can we improve T cell therapy by changing APC populations? Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 155). Retrieved from http://www.asi2013.org/

Jackson, C. (2013). Colorectal cancer in New Zealand: The PIPER project. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/conference_2013

Conference Contribution - Verbal presentation and other Conference outputs

Jackson, C. (2013, July). Metastatic colon and rectal cancer trial concepts. Verbal presentation at the Cancer Trials New Zealand Annual Scientific Meeting, Dunedin, New Zealand.

Jackson, C. (2013, May). Colorectal cancer. Verbal presentation at the Royal Australasian College of Surgeons (RACS) 82^nd Annual Scientific Conference, Auckland, New Zealand.

2012

Journal - Research Article

Pullar, J. M., Chisholm, A., & Jackson, C. (2012). Dietary information for colorectal cancer survivors: An unmet need. New Zealand Medical Journal, 125(1356). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Verbal presentation and other Conference outputs

Jackson, C. (2012, July). PIPER. Verbal presentation at the Cancer Trials New Zealand Annual Scientific Meeting, Auckland, New Zealand.

Jackson, C. (2012, May). Colorectal cancer in New Zealand: Stuck at the bottom of the world? Verbal presentation at the New Zealand Society for Oncology (NZSO) Conference, Wellington, New Zealand.

Jackson, C. (2012, November). Right patient, right drug, right time: Improving survival in metastatic melanoma. Verbal presentation at the New Zealand Association of Plastic Surgeons Annual Scientific Meeting, Dunedin, New Zealand.

2011

Journal - Research Article

Richter, K. K., Dempster, A., Tos, A. P. D., Premkumar, R., & Jackson, C. (2011). Challenging differential diagnosis of a wild-type gastrointestinal stromal tumour (GIST) or rare reticular perineurioma of the stomach? The role for mutational analysis. New Zealand Medical Journal, 124(1331). Retrieved from http://journal.nzma.org.nz/journal/124-1331/4583/content.pdf

Conference Contribution - Poster Presentation (not in published proceedings)

Ahmadi, O., Alfadhel, M., Allawati, H., Christie, J., McKenzie, B., Missen, S., … Vaatstra, W., Thompson-Fawcett, M., Derrett, S., Sharples, K., & Jackson, C. (2011, March). Staging and follow-up of Stage II and III colorectal cancer patients: Clinical audit at Dunedin Hospital. Poster session presented at the New Zealand Association of General Surgeons (NZAGS) Annual Scientific Meeting, New Plymouth, New Zealand.

Ahmadi, O., Song, A., Allawati, H., Alfadhel, M., Christie, J., McKenzie, B., Missen, S., Vaatstra, W., Sharples, K., Derrett, S., Thompson-Fawcett, M., & Jackson, C. (2011, March). Clinical audit of follow-up of patients with colorectal cancer after curative resection at Dunedin Hospital: Provisional results. Poster session presented at the New Zealand Association of General Surgeons (NZAGS) Conference: GI Surgery, New Plymouth, New Zealand.

2010

Journal - Research Article

Jackson, C., Sirohi, B., Cunningham, D., Horwich, A., Thomas, K., & Wotherspoon, A. (2010). Lymphocyte-predominant Hodgkin lymphoma: Clinical features and treatment outcomes from a 30-year experience. Annals of Oncology, 21(10), 2061-2068. doi: 10.1093/annonc/mdq063

Conference Contribution - Published proceedings: Abstract

Tiong, J., Jackson, C., Schlup, M., Lubcke, R., & Schultz, M. (2010). Advanced tumour stages do not correlate with therapeutic delay in colonic cancer. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf

Alfadhel, M., McKenzie, B., Ahmadi, O., Allawati, H., Christie, J., Missen, S., Song, A., … Sharples, K., Derrett, S., Thompson-Fawcett, M., & Jackson, C. (2010). Clinical audit of follow-up of patients with colorectal cancer following curative resection at Dunedin Hospital: Provisional results. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf

Pullar, J., Jackson, C., & Chisholm, A. (2010). Additional dietary information for colorectal cancer survivors. Nutrition & Dietetics. 67(Suppl. 2), (pp. 20-21). doi: 10.1261/j.1747-0080.2010.01440.x

2009

Journal - Research Article

Jackson, C., Cunningham, D., Oliveira, J., on behalf of the ESMO Guidelines Working Group. (2009). Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20(Suppl. 4), iv34-iv36. doi: 10.1093/annonc/mdp119

2008

Journal - Research Article

Kong, G., Jackson, C., Koh, D. M., Lewington, V., Sharma, B., Brown, G., … Cook, G. J. R. (2008). The use of ¹⁸F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI. European Journal of Nuclear Medicine & Molecular Imaging, 35(7), 1323-1329. doi: 10.1007/s00259-008-0743-z

Jackson, C., & Cunningham, D. (2008). Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer. European Journal of Cancer, 44, 652-662. doi: 10.1016/j.ejca.2008.01.021

2007

Journal - Research Article

Jackson, C., Mochlinski, K., & Cunningham, D. (2007). Therapeutic options in gastric cancer: Neoadjuvant chemotherapy vs postoperative chemoradiotherapy. Oncology, 21(9), 1084-1087.

Jackson, C., Starling, N., Chua, Y. J., & Cunningham, D. (2007). Pharmacotherapy for oesophagogastric cancer. Drugs, 67(17), 2539-2556.

2006

Journal - Research Article

Hung, N. A., Jackson, C., Nicholson, M., & Highton, J. (2006). Pregnancy-related polymyositis and massive perivillous fibrin deposition in the placenta: Are they pathogenetically related? Arthritis & Rheumatism, 55(1), 154-156. doi: 10.1002/art.21710

2003

Conference Contribution - Poster Presentation (not in published proceedings)

Wilbanks, S. M., McInnes, S. J., Jackson, C., McIntosh, S., Young, J., & Clark, S. J. (2003, February). Prolyl isomerase activity of the trigger factor molecular chaperone is not conserved. Poster session presented at the 28th Annual Lorne Conference on Protein Structure and Function, Lorne, Australia.

2002

Conference Contribution - Verbal presentation and other Conference outputs

Wilbanks, S. M., McInnes, S. J., Jackson, C., McIntosh, S., Young, J., & Clark, S. J. (2002, November). Prolyl isomerase activity of the trigger factor molecular chaperone is not conserved. Verbal presentation at the Microbes and Molecules Conference, Christchurch, New Zealand.